Brave Asset Management’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.1K | Hold |
25,000
| – | – | 0.01% | 158 |
|
|
2025
Q1 | $13.7K | Hold |
25,000
| – | – | ﹤0.01% | 154 |
|
|
2024
Q4 | $23.1K | Hold |
25,000
| – | – | 0.01% | 154 |
|
|
2024
Q3 | $22K | Hold |
25,000
| – | – | 0.01% | 157 |
|
|
2024
Q2 | $24.7K | Hold |
25,000
| – | – | 0.01% | 150 |
|
|
2024
Q1 | $26.8K | Hold |
25,000
| – | – | 0.01% | 157 |
|
|
2023
Q4 | $33.9K | Hold |
25,000
| – | – | 0.01% | 148 |
|
|
2023
Q3 | $54.9K | Buy |
25,000
+15,000
| +150% | +$33K | 0.02% | 134 |
|
|
2023
Q2 | $26.4K | Buy |
+10,000
| New | +$26.4K | 0.01% | 148 |
|
|
2023
Q1 | – | Sell |
-20,000
| Closed | -$32.8K | – | 154 |
|
|
2022
Q4 | $32.8K | Hold |
20,000
| – | – | 0.01% | 142 |
|
|
2022
Q3 | $25K | Hold |
20,000
| – | – | 0.01% | 135 |
|
|
2022
Q2 | $20K | Hold |
20,000
| – | – | 0.01% | 137 |
|
|
2022
Q1 | $32K | Hold |
20,000
| – | – | 0.01% | 151 |
|
|
2021
Q4 | $28K | Hold |
20,000
| – | – | 0.01% | 150 |
|
|
2021
Q3 | $42K | Hold |
20,000
| – | – | 0.01% | 146 |
|
|
2021
Q2 | $55K | Buy |
20,000
+10,000
| +100% | +$27.5K | 0.02% | 147 |
|
|
2021
Q1 | $38K | Buy |
+10,000
| New | +$38K | 0.01% | 142 |
|